Thiazolidinediones Prevent PDGF-BB-induced CREB Depletion in Pulmonary Artery Smooth Muscle Cells by Preventing Upregulation of Casein Kinase 2 α′ Catalytic Subunit
- 1 May 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cardiovascular Pharmacology
- Vol. 55 (5), 469-480
- https://doi.org/10.1097/fjc.0b013e3181d64dbe
Abstract
Background: The transcription factor CREB is diminished in smooth muscle cells (SMCs) in remodeled, hypertensive pulmonary arteries (PAs) in animals exposed to chronic hypoxia. Forced depletion of cyclic adenosine monophosphate response element binding protein (CREB) in PA SMCs stimulates their proliferation and migration in vitro. Platelet-derived growth factor (PDGF) produced in the hypoxic PA wall promotes CREB proteasomal degradation in SMCs via phosphatidylinositol-3-kinase/Akt signaling, which promotes phosphorylation of CREB at 2 casein kinase 2 (CK2) sites. Here we tested whether thiazolidinediones, agents that inhibit hypoxia-induced PA remodeling, attenuate SMC CREB loss. Methods: Depletion of CREB and changes in casein kinase 2 catalytic subunit expression and activity were measured in PA SMC treated with PDGF. PA remodeling and changes in medial PA CREB and casein kinase 2 levels were evaluated in lung sections from rats exposed to hypoxia for 21 days. Results: We found that the thiazolidinedione rosiglitazone prevented PA remodeling and SMC CREB loss in rats exposed to chronic hypoxia. Likewise, the thiazolidinedione troglitazone blocked PA SMC proliferation and CREB depletion induced by PDGF in vitro. Thiazolidinediones did not repress Akt activation by hypoxia in vivo or by PDGF in vitro. However, PDGF-induced CK2 α′ catalytic subunit expression and activity in PA SMCs, and depletion of CK2 α′ subunit prevented PDGF-stimulated CREB loss. Troglitazone inhibited PDGF-induced CK2 α′ subunit expression in vitro and rosiglitazone blocked induction of CK2 catalytic subunit expression by hypoxia in PA SMCs in vivo. Conclusion: We conclude that thiazolidinediones prevent PA remodeling in part by suppressing upregulation of CK2 and loss of CREB in PA SMCs.Keywords
This publication has 44 references indexed in Scilit:
- Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodelingAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ ActivationCell Metabolism, 2007
- Platelet-Derived Growth Factor BB Induces Nuclear Export and Proteasomal Degradation of CREB via Phosphatidylinositol 3-Kinase/Akt Signaling in Pulmonary Artery Smooth Muscle CellsMolecular and Cellular Biology, 2006
- Downregulation of protein kinase CKII is associated with cellular senescenceFEBS Letters, 2006
- Vascular Remodeling Versus Vasoconstriction in Chronic Hypoxic Pulmonary HypertensionCirculation Research, 2005
- cAMP Response Element-binding Protein Content Is a Molecular Determinant of Smooth Muscle Cell Proliferation and MigrationPublished by Elsevier BV ,2001
- Transcription Factors Ets1, NF-κB, and Sp1 Are Major Determinants of the Promoter Activity of the Human Protein Kinase CK2α GenePublished by Elsevier BV ,2000
- Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.JCI Insight, 1995
- Cell growth stimulation by EGF: Inhibition through antisense-oligodeoxynucleotides demonstrates important role of casein kinase IIExperimental Cell Research, 1991
- Casein kinase II is elevated in solid human tumours and rapidly proliferating non‐neoplastic tissueEuropean Journal of Biochemistry, 1990